INDV
Indivior Pharmaceuticals, Inc.
Stock
$35.71+0.33 (+0.93%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months |
|---|---|
| Revenue | $1.3B |
| Gross profit | $1.1B |
| Operating income | $421M |
| Net income | $355M |
| EPS | $2.77 |
| Free cash flow | −$111M |
Indivior Pharmaceuticals, Inc.
$35.71+0.33 (+0.93%)Close Oct 2, 2026
| Metric | Last 12 months |
|---|---|
| Revenue | $1.3B |
| Gross profit | $1.1B |
| Operating income | $421M |
| Net income | $355M |
| EPS | $2.77 |
| Free cash flow | −$111M |